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Unlike other cutaneous surfaces, the central portion of the 
corneal epithelium is typically devoid of Langerhans cells. 
The absence ofIa+ Langerhans cells in the central cornea is of 
more than casual interest and may explain the immunologic 
privilege that is characteristic of corneal allografts. The 
present communication summarizes previous studies that ex-
amined the role of corneal Langerhans cells in eliciting al-
loimmune resfonses and corneal graft rejection in rodents. 
Under norma circumstances, corneal allografts are poorly 
immunogenic when residing in the avascular ocular graft bed 
C orneal transplantation is arguably the oldest and most successful form of solid tissue transplantation. The first documented successful human corneal trans-plant was performed at the turn of this century [1]. During the ensuing 75 years, literally thousands of 
corneal transplants have been performed on human subjects. In the 
United States alone, over 30,000 corneal transplants are performed 
each year with a rejection rate less than 10% [1 j. This extraordinary 
success rate is particularly impressive considering that patients are 
not routinely tissue typed and do not normally receive systemic 
immunosuppressive drugs. 
The apparent ease with which corneal transplants escape immu-
nologic rejection has been attributed to the conspicuous absence of 
blood and lymphatic vessels in the corneal graft bed [2]. Indeed 
there is a large body of evidence to support the notion that the 
avascular corneal graft bed produces an afferent blockade of the 
systemic immune apparatus due to the sequestration of alloantigens 
[2] . We have proposed that, in addition to the avascular nature of the 
corneal graft bed, the unique absence of donor-derived Langerhans 
cells in the cornea contributes to the immunologic privilege of 
corneal allografts [1,2]. 
The central portion of the cornea of humans, as well as a wide 
range of mammalian species, is typically devoid of Langerhans cells 
[1,2]. Indeed, the absence of Ia+ Langerhans cells in the central 
cornea is of more than casual interest, because these cells represent 
an important immunogenic component of the allograft. It has been 
suggested that Ia + "passenger cells" are important immunogens 
and represent the major barrier to successful organ transplantation 
[3]. The consistent absence of Langerhans cells in that portion of the 
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even though the graft displays large quantities of alloanti-
gens. The afferent blockade of the immune response can be 
circumvented by donor-derived Langerhans cells that serve 
as potent immunogens for all categories of corneal allografts 
except grafts involving allodisparity only at class I major 
histocompatibility complex loci. Thus, the presence of 
donor-derived Langerhans cells exerts profound effects on 
the fate of corneal allografts. ] Invest Dermatol 99:104S-
106S, 1992 
cornea normally used for corneal transplantation offers an unusual 
opportunity to examine the role of "passenger cells" in general and 
Langerhans cells in specific, in the elicitation of alloimmune re-
sponses and allograft rejection. This review summarizes our efforts 
to evaluate the role of donor-derived Langerhans cells in eliciting 
corneal allograft rejection. In particular, we wished to determine 
the effect of donor-derived Langerhans cells in the context of spe-
cific categories of histocompatibility antigens. 
DYNAMIC DISTRIBUTION OF CORNEAL 
LANGERHANS CELLS 
Under normal circumstances, corneal Langerhans cells (LC) are 
organized in a well-defined, circumferential pattern in the transi-
tional area between the peripheral cornea and the conjunctiva. Cor-
neal LC are capable of migrating from the periphery to the central 
regions of the cornea following various stimuli including electro-
cautery [4], bacterial and viral infections [5,6] , and phagocytic stim-
uli [7]. We have shown that instillation of 1.0-J.l sterile latex beads 
into shallow epithelial incisions induces rapid, centripetal migra-
tion of peripheral LC into the central portions of the cornea [7]. 
Such "latex bead-treated," LC-containing corneas can be utilized 
as corneal grafts and compared to untreated corneal grafts as a facile 
method for evaluating the role of donor-derived LC in initiating 
allograft rejection. 
CORNEAL GRAFTS MISMATCHED AT THE MAJOR 
HISTOCOMPATIBILITY COMPLEX (MHC) AND 
MULTIPLE MINOR H LOCI (= FULLY ALLOGENEIC) 
All of the results reported here were from studies utilizing a well-
characterized orthotopic corneal allograft model in the rat [8]. The 
effect of donor-derived LC was assessed in a fully allogeneic donor-
host combination [8] . The immunologic privilege of corneal allo-
grafts was apparent by the high success rate of LC-free corneal 
allografts that underwent rejection in only 55% of the naive hosts 
[8]. By contrast, 96% (22 of 23) of the LC-containing grafts were 
rejected with a mean survival time (MST) of 11.8 ± 5.2 d [8]. The 
presence of donor-derived LC greatly enhanced the immunogenic-
ity of the fully allogeneic corneal allografts that was demonstrated 
by significant elevation of the cytotoxic T-lymphocyte responses 
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Table I. Rejection of Class I MHC Disparate Cornea Allografts· 
First Graft Second Graft Percent Corneal 
(Day 0) (Day 30) Graft Rejection 
Cornea (LC-) 18% 
Cornea (LC+) 20% 
Skin Cornea 100% 
Cornea (LC-) Skin 100% 
• Detai ls of the experiment arc published elsewhere [9] . 
[8]. Thus, the presence of donor LC virtually assured the rejection of 
fully allogeneic corneal allografts. 
REJECTION OF CORNEAL ALLOGRAFTS 
MISMATCHED ONLY AT CLASS I MHC LOCI 
Experiments simi!ar to. tho~e described above were performed using 
congenic rat strams dlffenng only at the class I MHC locus [9]. 
Although hosts pre-immunized with skin grafts always rejected 
subsequent class I MHC disparate corneal grafts from the same 
donor (100% rejection; MST = 13.3 ± 2.2 d), corneal grafts were 
rejected in only 18% of the naive hosts (Table I). Surprisingly, the 
presence of donor LC did not increase the reject~on of class I MHC 
disparate grafts. Even though the cla~s I MHC dlsp~rate grafts were 
poorly immunogenic,. they were .hlghly antigenic. Hosts subse-
quently imn~unlzed With donor sk11.l grafts rejected both the class I 
disparate skm grafts and the prevIOusly clear corneal allografts. 
Thus, the corneal graft bed provides afferent but not efferent block-
ade of the immune apparatus in te~ms of class I MHC alloantigens. 
Unlike the case of fully allogeneic grafts, the presence of donor-
specific LC does not circumvent the immunologic privilege ex-
tended to class I disparate corneal grafts. 
REJECTION OF CORNEAL ALLOGRAFTS 
MISMATCHED ONLY AT CLASS II MHC LOCI 
Studies involving corneal allografts exchanged between rat strains 
differing only at class II MHC loci provided important insights into 
the regulation of class II MHC antigens in the cornea [10]. Because 
none of the cells of the cornea normally express class II antigens, it 
was not surprising that none of the class II disparate grafts under-
went rejection (Table II). However, hosts pre-immunized with skin 
grafts rejected subsequent LC-free, class II disparate corneal allo-
grafts. This apparent paradox, in which grafts that were presumably 
class II MHC negative were rejected, was explained by the regula-
tion of class II MHC antigens on the corneal cells. LC-free corneal 
grafts were removed and examined by immunofluorescence for the 
expression of donor,class II MHC antigens at 24-h IIltervals follow-
ing transplantation onto naive hosts. Within 24 h of grafting, over 
25% of the corneal epithelial cells expressed class II MHC antigens 
and, by day seven, 100% of the cells displayed strong expression of 
class II MHC antigens [10]. By day 10, all of the corneal epithelial 
cells had returned to their origina l class II negative phenotype. 
Thus, the surgical procedure itself induced swift, albeit transient, 
Table II. Rejection of C lass II MHC Disparate 
Corneal Allografts· 
First Graft 
Cornea 
LC + Cornea 
Skin 
LC + Cornea 
LC - Cornea 
Second Graft 
nonc 
none 
Cornea (LC-) 
Cornea (LC-) 
Cornea (LC-) 
• Details of experiment are described elsewhere [10]. 
Percent Rejection 
(Second Graft) 
0% 
0% 
100% 
80% 
0% 
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Table III. Rejection of MHC Matched, Multiple Minor H 
Mismatched Corneal Grafts· 
LC - Cornea 
LC + Cornea 
Graft 
LC - Cornea (Preimmunc host)b 
LC - Cornea (Late latcx bead)' 
• Details of original experiment described elsewhere [10] . 
Percent 
Rejection 
26% 
59% 
100% 
10% 
I Hosts pre-immunized with skin grafts from same donor that provided subsequent 
corneal allograft. 
, Long-term surviving multiple minor H aisparate corneal grafts were treated with 
latex beads (> 60 d post-transplantation) to induce centripetal migration of Host LC 
into corneal allograft. 
expression of class II MHC antigens on the corneal allografts. In the 
case of the naive host receiving its first corneal allograft, the expres-
sion of class II MHC antigens dissipates before immunologic effec-
tor cells have been generated. By contrast, in the pre-immune host, 
the class II antigens induced by surgery provide targets for immuno-
logic attack by the pre-existing immune effector cells. Although the 
presence of donor-derived LC did not lead to the rejection of pri-
mary corneal all ografts, it did elicit potent systemic alloimmunity 
that culminated in swift rejection of subsequent LC-free corneal 
allografts transplanted to the contralateral eye. 
REJECTION OF CORNEAL ALLOGRAFTS 
MISMATCHED ONLY AT MULTIPLE MINOR H LOCI 
The effect of donor LC on the rejection ofMHC-identical, multiple 
minor H disparate corneal grafts was assessed [11]. As in all previous 
combinations, hosts pre-immunized with skin grafts always rejected 
subsequent corneal grafts. In naive hosts, however, the immuno-
logic privilege of minor H disparate grafts was apparent-rejection 
occurred in only 26% of the non-immune hosts (Table III). The 
presence of donor LC increased the alloimmunogenicity of these 
grafts significantly-rejection occurred in 59% of the latex bead-
treated corneal grafts. Further experiments evaluated the effect of 
the recipient'S LC on the fate of MHC matched, minor H disparate 
corneal grafts. Long-term surviving corneal grafts (> 60 d post 
grafting) were treated with latex beads to induce the migration of 
the r~cipient's own LC. Infiltration of corneal grafts with recipient 
LC did not affect the survival of multiple minor H disparate corneal 
grafts as only one of ten such grafts underwent rejection. Thus, the 
presence of donor LC greatly increases the immunogenicity and 
subsequent rejection of corneal grafts matched at the MHC but 
mismatched at multiple minor H loci. Infiltration of the surviving 
g~afts with recipient LC, however, does not jeopardize graft sur-
Vival or provoke alloimmunity. 
CONCLUSION 
The results summarized here indicate that the presence of donor-
derived LC can have a profound influence on the imlTIunogenicity 
and fate of corneal allografts. Under normal circumstances, corneal 
allografts are poorly immunogenic when residing in the avascular 
ocular graft bed even though the graft displays abundant quantities 
of alloantigens. This afferent blockade of the immune response can 
be circumvented by donor-derived LC that serve as potent immun-
ogens for all categories of corneal allografts except grafts involving 
allodisparity only at class I MHC loci. Thus, the remarkable imnlU-
nologic privilege of corneal allografts can be attributed to the avascu-
lar nature of the corneal graft bed, the absence oflymphatic drainage 
of the graft site, and the absence of donor-derived LC. One wonders 
if the occasional rejection of the human corneal allografts is the 
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result of the transplantation of an aberrant corneal graft that con-
tains donor-derived LC. 
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